Print this page    •   Back to Web version of article

U.S. News
Georgia: Emory University Receives $26 Million to Study AIDS Vaccine

July 20, 2011

Emory University has received a $26 million grant from the National Institutes of Health to develop a vaccine against HIV/AIDS. In a five-year study, the Emory Consortium for AIDS Vaccine Research in Nonhuman Primates will focus on preventing the initial stages of simian immunodeficiency virus infection; SIV is similar to HIV. The research at Emory's Yerkes National Primate Research Center will concentrate on blocking infection at mucosal sites. "Developing a safe and effective preventive HIV/AIDS vaccine is still a critical part of the fight against this challenging disease that affects more than 30 million people worldwide," said Eric Hunter, PhD, co-director of the Emory Center for AIDS Research, which supports more than 100 investigators carrying out AIDS-related research.

Back to other news for July 2011

Excerpted from:
Geogia Voice (Atlanta)
07.18.2011; Ryan Watkins

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.